Great ABX overview -- Cellceutix / Brilacidin even gets a mention (see Table 10)... DeGrado et al, prior PYMX research, also cited. IMO We have a silver/gold/platinum mine in our Defensin-Mimetics platform. And Kevetrin just might prove to be Cancer's Kryptonite. I'm blinded by the science's potential in a good way. 1st in Class ABX 1st in Class Onc More designations to come and partnerships. // (August 20, 2015) http://www.researchgate.net/profile/Chandradhish_Ghosh/publication/281174631_Membrane-Active_Small_Molecules_Designs_Inspired_by_Antimicrobial_Peptides/links/55dab38c08aeb38e8a8a1ca5.pdf